Efficiency of the use of sakubutril / valsartan on the increase in left ventricular ejection fraction in patients with coronary artery disease with HF sEFV with diabetes mellitus 2

29 June 2021 (08:00 - 08:00)
Organised by:
Congress Presentation Part of: Clinical Trial Updates Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2021

ESC 365 is supported by

ESC 365 is supported by